Micropaque Ct (Barium Sulfate)

Micropaque Ct is a barium sulfate suspension used for radiographic imaging of the gastrointestinal tract.

• Barium swallow: enables clear visualization of the esophagus for assessment of motility and structural lesions.
• Barium meal: outlines the stomach and duodenum to evaluate ulcer disease, tumors and anatomical abnormalities.
• Barium enema: delineates the large bowel for detection of polyps, strictures, inflammation and perforation.
• General gastrointestinal tract radiography: provides overall contrast for comprehensive GI studies.

• Barium sulfate acts as a radiopaque agent by densely reflecting X‑ray photons. When ingested, the suspension coats the mucosal surface of the gastrointestinal lumen, creating a high‑contrast outline that appears white on radiographs. Because the compound is not absorbed systemically, it remains confined to the GI tract, providing a safe and effective means of enhancing image definition without pharmacologic activity.

Adverse reactions to Micropaque Ct are generally related to the gastrointestinal tract and occasional systemic responses.

Common Side Effects

• Nausea: mild to moderate discomfort after ingestion.
• Abdominal cramping: transient pain during bowel transit.
• Constipation: slowed bowel movements following the procedure.
• Diarrhea: loose stools as the contrast moves through the intestines.
• Metallic taste: temporary alteration in oral sensation.
• Mild headache: occasional transient headache.

Serious or Rare Side Effects

• Barium impaction: blockage of the bowel requiring medical intervention.
• Allergic reaction: rash, itching or urticaria indicating hypersensitivity.
• Aspiration pneumonia: inhalation of the suspension leading to lung infection.
• Perforation risk: exacerbated if a pre‑existing bowel wall defect is present.
• Electrolyte imbalance: rare disturbances due to fluid shifts.
• Severe abdominal pain: may signal complications such as obstruction or perforation.

Before using Micropaque Ct, clinicians should evaluate patient‑specific factors and follow handling guidelines to minimize risks.

• Assess for bowel obstruction: avoid use if obstruction is suspected.
• Verify fasting status: administer after appropriate fasting period.
• Review allergy history: contraindicated in known hypersensitivity to barium sulfate.
• Ensure adequate hydration: encourage fluid intake after the study.
• Use caution in pregnancy: limited data, weigh risk versus benefit.
• Store at ambient temperature: keep below 25°C, protect from moisture and light.

Barium sulfate can interact with certain medications or substances that affect gastrointestinal imaging or patient safety.

Major Interactions (Avoid)

• Tetracycline antibiotics: may cause false‑positive imaging artifacts.
• Iron‑containing supplements: can produce radiopaque interference.
• Potassium iodide: may alter contrast distribution.
• Aluminum or magnesium antacids: can affect barium coating.
• High‑dose vitamin C: may modify GI motility and contrast appearance.

Moderate Interactions (Monitor Closely)

• Diuretics: risk of dehydration affecting contrast transit.
• Laxatives: may accelerate bowel clearance, reducing image quality.
• Antiemetics: can mask nausea related to the suspension.
• Opioids: slow gastrointestinal motility, increasing retention time.
• NSAIDs: may increase risk of GI irritation during the procedure.